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Abstract
Gastroesophageal reflux disease (GERD) is nowadays a 
highly prevalent, chronic condition, with 10% to 30% 
of Western populations affected by weekly symptoms. 
Many patients with mild reflux symptoms are treated 
adequately with lifestyle modifications, dietary changes, 
and low-dose proton pump inhibitors (PPIs). For those 
with refractory GERD poorly controlled with daily PPIs, 
numerous treatment options exist. Fundoplication is 
currently the most commonly performed antireflux 
operation for management of GERD. Outcomes described 
in current literature following laparoscopic fundoplication 
indicate that it is highly effective for treatment of GERD; 
early clinical studies demonstrate relief of symptoms 
in approximately 85%-90% of patients. However it 
is still unclear which factors, clinical or instrumental, 
are able to predict a good outcome after surgery. 
Virtually all demographic, esophagogastric junction 
anatomic conditions, as well as instrumental (such 
as presence of esophagitis at endoscopy, or motility 
patterns determined by esophageal high resolution 
manometry or reflux patterns determined by means of 
pH/impedance-pH monitoring) and clinical features (such 
as typical or atypical symptoms presence) of patients 
undergoing laparoscopic fundoplication for GERD can 
be factors associated with symptomatic relief. With this 
in mind, we sought to review studies that identified the 
factors that predict outcome after laparoscopic total 
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Core tip: Fundoplication is currently the most commonly 
performed antireflux operation for management of 
gastroesophageal reflux disease (GERD). Outcomes 
described in current literature following laparoscopic 
fundoplication indicate that it is highly effective for 
treatment of GERD. However it is still unclear which 
factors, clinical or instrumental, are able to predict a good 
outcome after surgery. Anatomical conditions seem to 
not be a risk factor for poor outcome. The predictability 
of success following laparoscopic fundoplication seems 
to be directly proportional to the degree of certainty 
that gastroesophageal reflux is the underlying cause of 
the patient’s complaints. Thus, performing an accurate 
pre-operative clinical and instrumental evaluation is 
mandatory.
Tolone S, Gualtieri G, Savarino E, Frazzoni M, de Bortoli 
N, Furnari M, Casalino G, Parisi S, Savarino V, Docimo L. 
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8(11): 719­728  Available from: URL: http://www.wjgnet.
com/1948­9366/full/v8/i11/719.htm  DOI: http://dx.doi.
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INTRODUCTION
Gastroesophageal reflux disease (GERD) is currently 
a common condition; usually 10% to 30% of Western 
populations refer a weekly incidence of GERD sym­
ptoms. It has been recognized as a significant public 
health concern in the West[1,2]. Usually, the major part 
of patients with mild GERD are treated effectively 
with dietary and lifestyle changes, and/or low­dosage 
proton pump inhibitors (PPIs)[3]. For patients with GERD 
refractory to PPIs, different treatments can be started. 
In factantireflux surgery, and endoscopic procedures 
exist for patients who will to undergo an operative 
intervention. Fundoplication is currently considered 
the surgical gold standard for GERD treatment. Since 
its first description by Rudolph Nissen in 1956[4], 
the development of laparoscopy have increased the 
use of fundoplication worldwide. The indications for 
antireflux surgery in GERD patients were stated by 
the American Gastroenterological Association in 2013: 
It can be indicated in a GERD patient responsive, but 
not compliant to acid suppression therapy; in GERD 
patients who continue to experience troublesome 
symptoms despite an adequate pharmacological 
therapy; and in GERD patient who experience persistent 
extraesophageal symptoms despite adequate PPI 
therapy[5]. 
LF outcomes (as reported in current literature) 
point out that this technique is highly effective in 
GERD patients; the relief of symptoms is present in 
85%­90% of subjects in the immediate post­operative 
period[6,7]. Despite these encouraging data, there can 
be complications that can necessitate a second inter­
vention: Re­herniation, disruption or twisting of the 
fundoplication, persistent dysphagia or reflux­related 
symptoms, gas bloat syndrome, and esophageal motor 
disfunction[8,9]. Also, it is not clear the real incidence 
of redo antireflux surgery, because of small sample 
size or are single center studies. In the 90’s, Lafullarde 
reported an overall reoperation rate of 10% after LF[10]. 
More recently, reoperation incidence is reported to be 
resembling 5%[11]. A systematic review performed on 
elective LF documented an overall reoperation incidence 
approximating 0.6%[12]. In the nationwide study from 
Denmark, an incidence near to 5% of redo antireflux 
surgery was reported in 2589 patients[13]. 
Being the increasing number of GERD patients 
without endoscopic esophagitis that are selected for 
LF, there is the need to highlight the great significance 
of a careful selection of patients who are likely to 
have a successful outcome after surgery. Virtually 
all demographic, esophagogastric junction anatomic 
conditions, as well as instrumental and clinical features 
of patients undergoing LF for GERD can be factors 
associated with a good outcome. With this in mind, we 
sought to review studies that identified the factors that 
could predict outcome after LF. 
DemOgRaphICs faCTORs (geNDeR, 
age, ObesITy, COmORbIDITIes)
Some studies revealed that gender can affect the clinical 
manifestation of GERD. Female gender with GERD 
showed at pH­monitoring a minor value of esophageal 
acid exposure and greater symptom scores than male 
gender cross­matched for grades of esophagitis[14,15]. 
In the same way, age seems to influence presentation, 
and GERD­related symptoms usually appear less 
severe in elderly, with a greater incidence of reflux 
complications[16]. In 2009, a study investigated the 
impact of gender and age on 5 years outcome of LF[17]. 
Authors showed that women were more likely to report 
a poorer outcome than men, describing heartburn, 
dysphagia and a lower satisfaction rate after surgery. 
Age, instead, did not prejudiced surgical outcome, 
even in presence of an higher incidence of complicated 
esophagitis and acid exposure in elderly than younger 
subjects[18]. These results were also confirmed by two 
large case series from Italy that compared antireflux 
surgical outcome in patients younger or older than 
65 years[19,20]. Overweight and obesity are associated 
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with increased intraabdominal pressure, presence of 
hiatal hernia, increased frequency of transient sphincter 
relaxation , diminished lower esophageal sphincter (LES) 
pressure, and and impaired gastric emptying, thus 
increasing esophageal acid exposure time (AET) and 
total number of reflux (TNR), which have a clear role in 
GERD and promoting symptoms[21,22]. Recently, Luketina 
et al[23] retrospectively evaluated antireflux surgical 
outcomes in obese patients compared to normal 
weight GERD patients. Body mass index (BMI) was 
not associated to poorer outcome; reduction in GERD 
symptom score, GERD recurrence and reoperation rates 
were similar in both obese and normal weight patients. 
These data are consistent to several case­series[24,25], 
whereas only few studies reported poorer outcomes 
after LF in obese subjects, with increased intraoperative 
difficulties, risk of recurrence and re­herniation[26]. 
Finally, a study performed on a large cohort from North 
Carolina suggested that presence of pre­operative 
comorbities, such as diabetes, hypertension or pul­
monary disease, were unlikely to impair the outcome of 
LF[27].
ClINICal faCTORs: sympTOms
Clinical presentation of GERD patients varies from 
typical to atypical symptoms, as well as extraesophageal 
symptoms and associated syndromes.
Heartburn and regurgitation are considered the 
hallmarks of reflux disease. Atypical reflux symptoms 
include non­cardiac chest pain and extraesophageal 
manifestations such as chronic cough, chronic asthma, 
chronic laryngitis, and dental erosions. Also, dyspepsia 
manifestations and irritable bowel syndrome symptoms 
can be present in up to 50% of GERD patients[28].
Many studies were performed to verify the post­
operative symptomatic gain after LF, in order to esti­
mate its clinical effectiveness. Morgenthal et al[29] 
studied a cohort of 166 subjects with 11 years follow­
up of; authors showed that typical symptoms presence 
was a predictive factor for a long term good outcome 
after LF. Lundell et al[30] performed a systematic review 
about the outcome of antireflux surgery. They found 
that patients did not experience heartburn substantially 
in the year after LF but it reappeared over time, with 
a certain amount of patients reporting heartburn after 
10 years. Similarly, patients reporting regurgitation 
reported a substantial reliefin the year after LF but with 
a recurrence 10 years after LF[30].
Achieving atypical GERD symptoms response 
is challenging: In a recent review, authors did not 
find any sure data on the efficacy of LF in relieving 
these manifestations, even if the majority of studies 
demonstrated some degree of improvement[31]. 
However, when a patient is selected on the basis of pH­
impedance monitoring, LF showed a significant relief 
of extraesophageal symptoms but it seems to cannot 
improve all of the patients. Adaba et al[32] studied 
respiratory symptoms in patients with GERD and then 
treated with LF. They stratified the study population into 
three groups; patients with cough only, patients with 
cough plus other respiratory symptoms (asthma, COPD, 
bronchitis, interstitial lung disease and hoarseness of 
voice) and patients with other respiratory symptoms 
only. Patients with cough only were likely to have a 
better symptoms improvement than patients with 
cough plus respiratory symptoms and respiratory 
symptoms only in the short and long term, even if the 
small number of patients represented a limitation. This 
trend has also been observed in other studies[33,34]. 
Overall response rates were over 70% in the control of 
respiratory manifestations. A recent review speculated 
that cough and reflux may stimulate each other[35].
Cough showed the highest preoperative scores than all 
extraesophageal manifestations and was referred by 
about 45% of the subjects. 
Finally, the presence of dyspepsia­like symptoms 
seems to be a negative factor for outcome. In fact, 
several studies reported that after surgery there are 
subjects who will get worse or exacerbate dyspepsia­
like symptoms (epigastric fullness, bloating, abdominal 
pain, flatulence), with worsening in GERD symptom 
control in up to 50% at long term follow­up[36,37].
ClINICal faCTORs: RespONse TO ppI
Acid­suppression with PPIs is the most widespread used 
therapy for GERD. Actually, patients who control their 
symptoms and resolve mucosal lesions with PPIs are 
referred to as “complete responders”, whereas “partial 
responders” or “non­responders” are those increasingly 
numbers of patients experiencing only partial or no relief 
from reflux symptoms, even after optimized PPI[38]. 
The LF is currently contemplated in patients with hiatus 
hernia and, according to some surgeons, in patients 
non­responsive to PPI[39], whereas other surgeons do 
not consider the surgical treatment as a good option in 
PPI non­responders.
Several studies evaluated the clinical effectiveness 
of surgical treatment of GERD in PPI responders 
and nonresponders. According to Lundell et al[30], 
partial responders were the ones needing to use 
acid­suppressive medication and requiring surgical 
reintervention after LF. These results are consistent with 
a recent study; authors in fact showed that the pre­
operative symptomatic response to PPI treatment was an 
excellent predictor of the subsequent response to LF[40]. 
In Campos et al[41] performed a multivariate analysis, 
demonstrating that pre­operative PPI refractoriness 
was a predictive factor of poor outcome after LF. In 
fact, PPI non­responders patients had a significantly 
effectiveness from the surgical treatment but it was still 
less successful when matched with PPI responders. Also, 
other studies considered the surgical outcome in non­
responders, evaluating those also affected by atypical 
symptoms, reflecting that surgical procedure can be 
uneffective to treat atypical symptoms. Hamdy et coll, 
therefore, realized a prospective study on patients 
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93% of subjects a normal instrumental testing was 
present, with a good overall satisfaction. Cowgill et al[47] 
compared a group of patients with GERD that had a 
normal LES resting pressure, to a group of patients with 
inadequate LES, before and after LF was performed. 
They found that before surgery, patients with normal 
LES tone had symptom scores (for heartburn and 
regurgitation) similar to those patients with inadequate 
LES, and the symptom relief was also similar after 
LF. Inability to belch was not frequent at baseline, 
and its presence did not increased postoperatively. 
Furthermore, dysphagia scores significantly improved 
in patients, irrespective for inadequate and adequate 
LES pressure, whereas dysphagia frequency did not 
improve in those adequate or inadequate LES pressure 
at manometry.
eNDOsCOpIC faCTORs: esOphagITIs, 
NeRD aND be
Deterioration of esophageal clearance function protracts 
contact of the refluxate, thus increasing mucosal 
damage, that can be documented during endoscopy. 
Therefore, GERD patients may present with a broad 
spectrum of endoscopic mucosal presentation (normal 
to esophagitis to BE).
However, a the majority of patients complaining 
GERD symptoms have no mucosal lesions at endo­
scopical imaging[48,49], while in others gastric acid 
reflux may trigger ERD and causing a weakening of 
esophageal peristalsis[50]. It could be expected that 
GERD patients without esophagitis suffer of a less 
symptomatic disease, and that the presence or absence 
of esophagitis at the endoscopic exam, could somehow 
influence the management of those patients, expecting 
that NERD patients could be treated with medical 
therapy whereas patients with esophagitis would 
need other approaches instead. Additionally, it could 
be thought that NERD subjects would have superior 
perioperative outcomes than ERD patients, but having 
less favorable long­term outcomes when compared to 
the ERDs.
Recently, there are confirmation that NERD subjects 
are similar to ERDs for reflux patterns, symptoms 
severity, and use of medical therapy[51].
Additionally, recent reports advocate that a less 
aggressive therapy (cisapride, anti­H2) in NERD 
subjects is often ineffective, and they necessitate high­
dose PPI; also, they experience relapse frequently, and 
a lower response rates to omeprazole when compared 
to ERDs[52,53]. For these reasons, management strategies 
for NERD should be based on the same principles as 
those for ERD.
Lots of studies were taken to evaluate preoperative 
influence of esophagitis in GERD patients, and to 
evaluate how the presence of erosions would affect the 
outcome of surgery. The hypotheses that NERD patients 
would have better perioperative results with less 
responders and non­responders who underwent LF[42]. 
The two groups were matched for endoscopic grading 
of esophagitis as well as no significant difference 
between the two groups on functional assessment on 
esophageal manometric study of LES pressure and pH­
monitoring. According to their findings, clinical outcome 
was better in PPIs responders regarding disappearance 
of heartburn and regurgitation, while there was no 
difference in improvement of dysphagia between both 
groups. Also, overall patient satisfaction with surgery 
was significantly higher in the good responders. Authors 
concluded that patients responder to PPI have a 
positive predictive factor for LF outcome, whereas PPI 
non responders are not at risk for a contraindication. 
However, PPI non­responders have experienced the 
failure of the pharmacological therapy, evaluating the 
surgical treatment as the last opportunity for their 
relief. So that, surgeons and gastroenterologists should 
accurately and carefully select patients non­responders 
to maximize LF outcomes: PPI non responders and/
or patients complaining atypical digestive symptoms 
should avoid a surgical procedure to treat GERD, if the 
real presence of GERD and a possible symptom-reflux 
correlation is not documented.
aNaTOmICal faCTORs: hIaTal 
heRNIa pReseNCe
Mechanisms of GERD are multifactorial (dysfunction 
of esophageal peristalsis, gastric activity, and LES 
continence). The presence of hiatal hernia exposes 
patients to increased AET, TNR and to a more severe 
GERD pattern[43]. In literature in fact, is currently 
reported that at baseline hiatus hernia, LES resting 
pressure and length are significantly more compromised 
in patients with severe erosive reflux disease (ERD) and 
Barrett’s esophagus (BE) compared to those with mild 
erosions and non erosive reflux disease (NERD).
Intuitively, GERD patients with a normal LES pre­
ssure at manometry would have less acid reflux and 
related symptoms at baseline; thus, they could be 
more likely to experience dysphagia after LF, with 
generally worse outcomes. On the other hand, hiatal 
hernia is often found in patients reporting dissatisfaction 
and/or undergoing reoperativeantireflux surgery. Its 
persistence after LF is in fact a predictive factor of 
negative outcome[44].
Lord et al45] demonstrated not only that the grade 
of GERD well links with the functional and anatomical 
qualities of the gastroesophageal reflux barrier, with 
hiatus hernia, and that a defective LES is significantly 
more frequent in ERD or BE patients, but also that 
LF, which resolves the hernia and increases the LES 
pressure, offers in the same way good or excellent 
outcomes, irrespective of the presence of mucosal 
inflammation, and in all degrees of GERD[45]. Similarly, 
Lei et al[46] study the effect of LF in treating sliding hiatal 
hernia. They found that at 2 years follow­up in up to 
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prolonged postoperative dysphagia after LF[64,65]. Even if 
several studies reported excellent outcomes after LF in 
patients with manometric motor disorders, these results 
are not entirely shared. Dysphagia can observed in a 
considerable amount (up to 20%) of GERD patients and 
esophageal motor abnormalities after LF[66,67].
The study conducted from D’Alessio et al[68], showed 
that patients with esophageal motor dysfunction 
determined at manometry had adequate outcomes 
after LF if they were able to effectively clear a food 
bolus at preoperative esophagography. These patients 
had similar outcomes to those with normal esophageal 
motor function. Pizza et al[69], studied different patients 
divided into groups according to the motility pattern 
studied preoperatively with manometry. They divided 
a group A with impaired esophageal peristalsis, and 
group B without impaired peristalsis. Their study 
demonstrated that the two groups had a statistically 
significant improvement in symptom score and that 
preoperative defective esophageal peristalsis was not a 
contraindication to LF.
Another aspect to be considered is the preoperative 
LES resting pressure at manometry, because experience 
with LF in GERD patients and manometrically intact 
LES is limited. In the majority of GERD subjects an 
impaired LES competence is documented at esophageal 
manometry, thus reflux presence is easily argued. In 
those with manometrically adequate LES, several other 
mechanisms (transient involuntary relaxations of the 
LES, impaired esophageal peristalsis, decreased gastric 
emptying, increased intragastric or intraabdominal 
pressure, increased BMI, life­style habits) have been 
proposed to explain the occurrence of GERD. 
Riedl et al[70] studied the importance of LES pressure 
and its hypothetic capacity to influence the outcome of 
LF when a normal pressure was present. In their study, 
they stratified 4 groups: Group I (LES with a defective 
intra­abdominal length and a defective pressure), group 
II (defective LES pressure), group III (defective LES 
intra­abdominal length), and group IV (normal LES). 
They found no significant differences among the groups 
regarding the quality of GERD symptoms and quality of 
life scores. Similar conclusions led the study of Patti et 
al[71] where authors studied three groups based on the 
preoperative LES pressure. The resolution of symptoms 
and incidence in the novo dysphagia was similar among 
the three groups, irrespective of the preoperative LES 
status. Also, authors found that LF was linked to a 
higher percentage of postoperative dysphagia than 
partial fundoplication, regardless the LES pressure at 
baseline.
Finally, a new parameter at high resolution mano­
metry, the esophagogastric junction contractile integral, 
was recently used to better prove the antireflux barrier 
efficacy of the junction[72]. The group from St Louis 
showed that this metric distinguished patients with 
normal AET from those with pathological values better 
than conventional LES parameters, and that it can 
be useful to evaluate the efficacy of the anti­reflux 
favorable long­term outcome than ERD is false. LF is an 
efficient treatment for GERD, with no significant clinical 
differences between patients with and without ERD at 
baseline. For patients with NERD, LF offers significant 
relief of symptoms and a marked diminution in the use 
of PPI[54].
Some investigators reported relatively poorer 
outcomes of LF for patients with BE and suggested 
the use of more aggressive surgical strategies for BE 
developed in GERD patients[55]. However, a study from 
Cowgill et al[56] compared patients with GERD with 
or without BE to verify the presence of differences 
in symptoms relative frequency and severity and in 
relative levels of acid reflux preoperatively and to 
verify symptom improvement postoperatively. Authors 
postulated that patients with BE would experience 
more severe reflux and symptoms at baseline, with 
poorer effects after LF than patients without BE. 
However, before surgery, even if BE patients showed 
higher DeMeester scores, symptom scores were not 
significantly different than patients without BE. After LF, 
symptoms scores improved for both group of patients. 
After LF, all symptoms scores significantly improved, 
whereas dysphagia frequency was higher in patients 
with BE. Similarly, Abbas et al[57] noticed that 67% of 49 
BE patients after LF were asymptomatic at follow­up. 
Also, Oelschlager et al[58] reported excellent outcomes in 
GERD and BE patients, with up to 95% of the subjects 
reporting a persistent symptomatic improvement after 
LF. Tolone et al[59] showed optimal reflux control in BE 
patients after LF, documenting it by the means of MII­
pH monitoring; also Authors showed regression of low 
grade dysplasia one year after surgery. 
INsTRUmeNTal feaTURes: mOTIlITy
Esophageal dysmotility commonly occurs with GERD. 
In the study by Savarino et al[60], which combined 
esophageal manometry and impedance, patients 
with reflux esophagitis have been shown to have a 
significant increase in esophageal motility and bolus 
transit abnormalities compared to healthy controls and 
patients with NERD. Although the association between 
GERD and esophageal dysmotility is clear, GERD 
symptoms relief after medical therapy is not proven 
to be helpful in improving esophageal motility. In fact, 
although PPIs are able to fully resolve reflux esophagitis 
and are successful in the majority of patients in terms 
of symptom relief, it has been shown that they have 
no effect on the improvement of esophageal body 
motility[61]. On the other hand, the surgical correction of 
GERD offers an improvement or a complete resolution 
of esophageal dysmotility[62]. However, medical good­
sense purposes a limited role for LF if esophageal 
dysmotility is present, fearing for postoperative dys­
phagia development. Coherently, successful results 
after LF in patients with esophageal motor dysfunction 
are not easy to predict[63]. Various studies considered 
ineffective esophageal motility not to be a risk factor for 
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studies comparing long­term objective and subjective 
parameters are lacking.
INsTRUmeNTal feaTURes: 
ImpeDaNCe-ph mONITORINg
Combined multichannel intraluminal impedance­pH 
(MII–pH) monitoring can identify reflux events inde­
pendently of its pH quality. In recent years, in fact, MII­
pH monitoring has become a progressively adopted 
method in the evaluation of GERD. Because MII­
pH monitoring detects retrograde movements in the 
esophagus regardless of an acid pH drop, it permits to 
document either nonacid or weakly acidic reflux events 
(with a pH higher than 4). This central advantage allows 
to evaluate GERD patients with refractory symptoms 
during acid­suppression therapy; in fact, recent studies 
have shown the capacity of MII­pH monitoring in 
increasing the symptom index sensitivity for patients on 
PPIs[84,85].
Mainie et al[86] assessed LF as a management for 
patients with PPI refractory symptoms associated 
with reflux, by means of MII­pH monitoring. Authors 
found that at baseline 18 of 19 patients had a positive 
symptom index and one, a negative symptom index. At 
postoperative follow­up (14 mo), 94% of patients with 
a positive symptom index were asymptomatic or with 
a marked improvement. Persistent symptoms were 
experienced in the patient with a negative symptom 
index, and one patient had recurrent symptoms after 
9 mo. Authors concluded that patients resistant to PPI 
with a positive symptom index demonstrated by MII­pH 
monitoring could be managed successfully by LF.
Del Genio et al[87] in 2008 verified if the MII-pH was 
effective to provide a correct selection of patients for LF. 
Authors prospectively assessed and reviewed data from 
314 consecutive patients not responsive or not compliant 
to PPI who underwent MII­pH for GERD. One hundred 
fifty-three patients who underwent LF with a minimum 
follow­up of 1 year were included in the study. Outcomes 
were reported for patients with normal and ineffective 
peristalsis and for patients with positive pH­monitoring, 
negative pH­monitoring and positive total number of 
reflux episodes at MII, and negative pH-monitoring and 
normal number of reflux episodes at MII and a positive 
symptom index correlation with MII (hypersensitive 
esophagus patients). The overall patient satisfaction rate 
after surgery was 98.3%. No differences in patients’ 
satisfaction and clinical postoperative symptom score 
were recorded between the groups as stratified by MII-
pH. Authors concluded that MII­pH provided a useful 
objective selection of patients for LF and that LF can 
provide excellent outcomes in either patients with 
positive pH or negative pH and positive MII monitoring 
or symptom index association. These results were later 
confirmed by another Italian group that documented the 
positive impact of LF on reflux control in patients who 
surgery[73].
INsTRUmeNTal feaTURes: 
esOphageal aCID expOsURe
Outstandingly, GERD patients are really a heterogeneous 
population. By means of 24­h ambulatory esophageal 
pH monitoring, AET can be quantified and qualified 
depending on the body position in which it appears. 
According this latter feature, three reflux patterns of 
acid reflux at pH­monitoring are usually reported: 
Unique upright, unique supine, and bipositional one. The 
presence of abnormal supine and bipositional AET are 
considered classic indication for antireflux surgery[74]. 
However, some investigators believe that symptom 
improvement and success after LF could depend 
upon the AET­body position pattern. It is reasonable 
to accept that LF outcomes can vary according to 
the reflux patterns. Upright reflux, for example, is 
cogitated to be a less severe GERD pattern, whereas 
bipositional reflux seems to be associated with 
advanced, severe disease. Although upright reflux is 
considered an initial form of GERD, these subjects are 
supposed to present a greater incidence of aerophagia 
and dyspepsia. Also, these patients are supposed to 
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CONClUsION
The LF is a good and efficacy therapeutical option for 
GERD. However, due to great heterogeneity in the 
phenotypical appearance of GERD, it is arguable that the 
outcomes of LF can be affected by a great number of 
factors. Based on the results highlighted in literature, a 
correctly fashioned LF, and, more important, a correctly 
indication to LF can provide optimal results with good 
patient satisfaction. Thus, in large part, the predictability 
of success following LF is directly proportional to the 
level of certainty that GERD is the underlying cause 
of the patient’s symptoms. Pre­operative testing are 
mandatory, especially MII­pH, due to its ability to better 
stratify GERD patients and to better identify the reflux-
symptom association.
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